Cardiology

Grappling with Hypertriglyceridaemia Rosetta Stone or Pandora’s Box?

Grappling with Hypertriglyceridaemia Rosetta Stone or Pandora’s Box? – MM1506

Hypertriglyceridaemia is caused by interactions between many genetic and nongenetic factors and is a common risk factor for atherosclerotic cardiovascular disease (CVD). Treatment of hypertriglyceridaemia relies on correcting secondary factors and unhealthy lifestyle habits, particularly poor diet and lack of exercise. Pharmacotherapy is indicated for patients with established CVD and those at moderate-to-high risk of CVD.

Modern Medicine – June 2015

June 23, 2015 by Cardiology Diabetes Obesity

Dilated Cardiomyopathy: A Diagnostic and Therapeutic Challenge

Dilated Cardiomyopathy: A Diagnostic and Therapeutic Challenge – MM1505

Nonischaemic dilated cardiomyopathy is an important and not infrequently encountered presentation in general practice. Diagnosis is often delayed due to the nonspecific nature of early symptoms and a lack of suspicion of ‘cardiac problems’ by both the patient and doctor. GPs play an important role in the management of this chronic disease, which has no cure but can be successfully managed for many years.

Modern Medicine – May 2015

May 26, 2015 by Cardiology

Venous Thromboembolism | Prevention, Investigation and Treatment

Venous Thromboembolism | Prevention, Investigation and Treatment – MM1504

People at risk of developing venous thromboembolism (VTE) need to be identified so that they can commence prophylaxis, which may prevent significant morbidity and mortality. Investigation of the underlying cause of VTE is essential because this affects the duration and type of treatment.

Modern Medicine – April 2015

April 28, 2015 by Cardiology Critical Care Pulmonology

Detecting and Managing Depression in Patients with Cardiac Disease

Detecting and Managing Depression in Patients with Cardiac Disease – MM1503

Depression is common in patients with cardiac disease, is associated with increased risk of mortality and morbidity and is the major driver of quality of life. Depression is also a major determinant of adherence to treatment strategies. It is therefore important that depressive symptoms are recognised and treated early in patients with cardiac disease.

Modern Medicine – March 2015

March 31, 2015 by Cardiology CNS Depression Psychiatry

Telmisartan More Than an Antihypertensive

Telmisartan More Than an Antihypertensive – MM1502

Telmisartan, a well established angiotensin type 1 receptor antagonist,
is indicated for the reduction of cardiovascular morbidity in patients with manifest atherothrombotic cardiovascular disease (CVD) or type 2 diabetes mellitus with documented target organ damage, as well as for the treatment of hypertension.

Modern Medicine – February 2015

February 24, 2015 by Cardiology Hypertension

STEMI – A Medical Emergency | An overview of management

STEMI – A Medical Emergency | An overview of management – MM1410

ST-segment elevation myocardial infarction (STEMI) is a medical emergency and patients presenting with this in general practice should be given aspirin and glyceryl trinitrate and sent urgently to hospital by ambulance for reperfusion. GPs have a pivotal role in the post-discharge care of these patients.

Modern Medicine – October 2014

October 28, 2014 by Cardiology

Fibrate Therapy for Dyslipidaemia and Prevention of Cardiovascular Disease

Fibrate Therapy for Dyslipidaemia and Prevention of Cardiovascular Disease – MM1410

The main use of fibrates is for the treatment of dyslipidaemia to lower plasma triglyceride levels and to raise HDL-cholesterol (HDL-C) levels. The effects of fibrates on LDL-cholesterol levels vary. Fibrates may be used either as monotherapy or in combination with statins. When combined with statins, fenofibrate is the preferred fibrate as it has a low risk of myopathy. The benefits of fibrate therapy in preventing ischaemic cardiovascular disease events appear to be confined to patients with baseline dyslipidaemia (raised triglyceride levels and/or low HDL-C levels).

Modern Medicine – October 2014

October 28, 2014 by Cardiology Hypertension
Verified by ExactMetrics